secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENZO BIOCHEM INC (—)
CIK:        0000316253
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001213900-23-081566
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enzo Biochem appoints Steven J. Pully as Chairman of the Board effective Oct 26, 2023
--------------------------------------------------------------------------------

- Steven J. Pully appointed to Board and Audit Committee; serves as Chairman.
- Receives RSU award with cash value of $100,000; 25% vests in 30 days, balance cliff vests after one year.
- Also receives cash compensation per non-employee director plan as described in prior proxy statement.
- Board adopted amended and restated bylaws enhancing procedural mechanics for shareholder nominations and Rule 14a-19.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/0001213900-23-081566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/316253/000121390023081566/ea187417-8k_enzobio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-081566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer